Episode 73: Genentech's Quita Highsmith
from The MM+M Podcast Hosted by The MM+M Podcast
Genentech isn’t currently developing a SARS-CoV-2 vaccine or therapeutic, but the biotech has been conducting research that could bring insight to bear on the willingness among communities of color to engage in clinical trials for COVID-19 vaccines and treatments. Quita Highsmith, Genentech’s chief diversity officer, speaks about that, and the biotech’s own efforts to recruit and instill more trust among underserved and medically disenfranchised patients.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The MM+M Podcast?
This episode is 26 minutes long.
When was this The MM+M Podcast episode published?
This episode was published on October 28, 2020.
Can I download this The MM+M Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.